CD19 and B-cell chronic lymphocytic leukemia: Flow cytometric immunophenotyping of peripheral blood lymphocytes confirmed the presence of 94.5% (19,781/μl) CD19+ B cells, 87.6% of them beating the T cell marker CD5+, aberrantly and commonly expressed in B cell chronic lymphocytic leukemia (Figure 1B).